OxySure Systems, Inc. (OXYS) Extends Market Reach in Hong Kong, Macau with New Distribution Partner

MissionIR would like to highlight OxySure® Systems Inc. (OTCQB: OXYS), a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale.

In the company’s news,

OxySure Systems reports that Pacific Medical Systems Ltd. has agreed to be the exclusive distributor of OxySure products in Hong Kong and Macau.

Pacific Medical Systems is a distributor of automated external defibrillators (AEDs) in Hong Kong, a region without time-consuming registration requirements. The new three-year agreement with OxySure requires minimal sales order commitment of 11,800 units of the OxySure Model 615 and OxySure Replacement Cartridges through the course of the agreement.

“We are pleased to add Pacific Medical Systems to our growing list of global distribution partners,” Julian Ross, CEO of OxySure, stated in the news release. “Pacific Medical Systems has been a trailblazer in the sale of AEDs in Hong Kong and we look forward to working with Jules Flach and his team to establish a strong presence in Hong Kong and Macau for OxySure. What is unique about Hong Kong in particular is that there is currently no mandatory medical device registration or approval process which means we can get down to business right away.”

Based in North Point, Hong Kong, Pacific Medical Systems specializes in the marketing, sales, and after sales support of innovative medical products in the Asia Pacific region. The company is comprised of professionals with experience from multinational companies in the medical field.

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

To sign up for The MissionIR Report, please visit http://MissionIR.com

To connect with MissionIR via Facebook, please visit http://Facebook.com/MissionIR

To connect with MissionIR via Twitter, please visit http://Twitter.com/MissionIR

Please read FULL disclaimer on the MissionIR website: http://Disclaimer.MissionIR.com

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

###